Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain

被引:110
作者
Huang, Rong-qin [1 ]
Ke, Wei-lun [1 ]
Qu, Ying-hua [1 ]
Zhu, Jian-hua [1 ]
Pei, Yuan-ying [1 ]
Jiang, Chen [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
BCECs; lactoferrin; lactoferrin receptors; membrane preparations; receptor-mediated endocytosis;
D O I
10.1007/s11373-006-9121-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
We present, herein, the evidence for lactoferrin (Lf) binding sites in brain endothelial capillary cells (BCECs) and mouse brain. The results from confocal microscopy showed the presence of Lf receptors on the surface of BCECs and the receptor-mediated endocytosis for Lf to enter the cells. Saturation binding analyses revealed that Lf receptors exhibited two classes of binding sites in BCECs (high affinity: dissociation constant (K (d)) = 6.77 nM, binding site density (B (max)) = 10.3 fmol bound/mu g protein; low affinity: K (d) = 4815 nM, B (max) = 1190 fmol bound/mu g protein) and membrane preparations of mouse brain (high affinity: K (d) = 10.61 nM, B (max) = 410 fmol bound/mu g protein; low affinity: K (d) = 2228 nM, B (max) = 51641 fmol bound/mu g protein). The distribution study indicated the effective uptake of I-125-Lf in brain after intravenous administration. The present study provides experimental evidence for the application of Lf as a novel ligand for brain targeting.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 27 条
[1]
Cellular internalization of lactoferrin in intestinal epithelial cells [J].
Ashida, K ;
Sasaki, H ;
Suzuki, YA ;
Lönnerdal, B .
BIOMETALS, 2004, 17 (03) :311-315
[2]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]
The physiology of lactoferrin [J].
Brock, JH .
BIOCHEMISTRY AND CELL BIOLOGY, 2002, 80 (01) :1-6
[4]
Brain endothelial cells as pharmacological targets in brain tumors [J].
Demeule, M ;
Régina, A ;
Annabi, B ;
Bertrand, V ;
Bojanowski, MW ;
Béliveau, R .
MOLECULAR NEUROBIOLOGY, 2004, 30 (02) :157-183
[5]
Eda S, 1996, BIOL PHARM BULL, V19, P167, DOI 10.1248/bpb.19.167
[6]
EXPRESSION OF LACTOFERRIN RECEPTORS IS INCREASED IN THE MESENCEPHALON OF PATIENTS WITH PARKINSON DISEASE [J].
FAUCHEUX, BA ;
NILLESSE, N ;
DAMIER, P ;
SPIK, G ;
MOUATTPRIGENT, A ;
PIERCE, A ;
LEVEUGLE, B ;
KUBIS, N ;
HAUW, JJ ;
AGID, Y ;
HIRSCH, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9603-9607
[7]
Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier [J].
Fillebeen, C ;
Descamps, L ;
Dehouck, MP ;
Fenart, L ;
Benaïssa, M ;
Spik, G ;
Cecchelli, R ;
Pierce, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7011-7017
[8]
Grau AJ, 2001, MOVEMENT DISORD, V16, P131, DOI 10.1002/1531-8257(200101)16:1<131::AID-MDS1008>3.0.CO
[9]
2-O
[10]
Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo [J].
Hatakeyama, H ;
Akita, H ;
Maruyama, K ;
Suhara, T ;
Harashima, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 281 (1-2) :25-33